Trial · NCT00105079
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL | Saquinavir/Ritonavir | Pts. with HIV-1 RNA Viral Load <50 copies/mL - YES | 108 | participants | |
| Number of Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL | Lopinavir/Ritonavir | Pts. with HIV-1 RNA Viral Load <50 copies/mL - YES | 108 | participants | |
| Number of Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL | Saquinavir/Ritonavir | Pts. with HIV-1 RNA Viral Load <50 copies/mL - NO | 59 | participants | |
| Number of Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL | Lopinavir/Ritonavir | Pts. with HIV-1 RNA Viral Load <50 copies/mL - NO | 62 | participants | |
| Number of Patients With HIV-1 RNA Viral Load <50 and <400 Copies/mL | Saquinavir/Ritonavir | Patients with <50 Copies/mL | 108 | 57.4 to 71.9 | participants |
| Number of Patients With HIV-1 RNA Viral Load <50 and <400 Copies/mL | Lopinavir/Ritonavir | Patients with <50 Copies/mL | 108 | 56.3 to 70.8 | participants |
| Number of Patients With HIV-1 RNA Viral Load <50 and <400 Copies/mL | Saquinavir/Ritonavir | Patients with <400 Copies/mL | 121 | 65.7 to 79.2 | participants |
| Number of Patients With HIV-1 RNA Viral Load <50 and <400 Copies/mL | Lopinavir/Ritonavir | Patients with <400 Copies/mL | 127 | 68.2 to 81.2 | participants |
| Change From Baseline in HIV-1 RNA Viral Load | Saquinavir/Ritonavir | Baseline | 5.20 | 95% Confidence Interval 5.1 to 5.3 | copies/mL |
| Change From Baseline in HIV-1 RNA Viral Load | Lopinavir/Ritonavir | Baseline | 5.17 | 95% Confidence Interval 5.1 to 5.3 | copies/mL |
| Change From Baseline in HIV-1 RNA Viral Load | Saquinavir/Ritonavir | Week 48 (n=126,133) | 1.80 | 95% Confidence Interval 1.8 to 1.9 | copies/mL |
| Change From Baseline in HIV-1 RNA Viral Load | Lopinavir/Ritonavir | Week 48 (n=126,133) | 1.83 | 95% Confidence Interval 1.8 to 1.9 | copies/mL |
| Change From Baseline in HIV-1 RNA Viral Load | Saquinavir/Ritonavir | Change from Baseline to Week 48 (n=126,133) | -3.39 | 95% Confidence Interval -3.5 to -3.3 | copies/mL |
| Change From Baseline in HIV-1 RNA Viral Load | Lopinavir/Ritonavir | Change from Baseline to Week 48 (n=126,133) | -3.36 | 95% Confidence Interval -3.5 to -3.2 | copies/mL |
| Change From Baseline in Cluster Differentiation Antigen 4 Positive (CD4+) Lymphocyte Count | Saquinavir/Ritonavir | Baseline (n=166,169) | 141.5 | 95% Confidence Interval 108.0 to 168.0 | cells/mm^3 |
| Change From Baseline in Cluster Differentiation Antigen 4 Positive (CD4+) Lymphocyte Count | Lopinavir/Ritonavir | Baseline (n=166,169) | 142.0 | 95% Confidence Interval 116.0 to 187.0 | cells/mm^3 |
| Change From Baseline in Cluster Differentiation Antigen 4 Positive (CD4+) Lymphocyte Count | Saquinavir/Ritonavir | Week 48 (n=122,131) | 319.0 | 95% Confidence Interval 277.0 to 370.0 | cells/mm^3 |
| Change From Baseline in Cluster Differentiation Antigen 4 Positive (CD4+) Lymphocyte Count | Lopinavir/Ritonavir | Week 48 (n=122,131) | 348.0 | 95% Confidence Interval 317.0 to 401.0 | cells/mm^3 |
| Change From Baseline in Cluster Differentiation Antigen 4 Positive (CD4+) Lymphocyte Count | Saquinavir/Ritonavir | Change from Baseline to Week 48 (n=121,130) | 178.0 | 95% Confidence Interval 159.0 to 213.0 | cells/mm^3 |
| Change From Baseline in Cluster Differentiation Antigen 4 Positive (CD4+) Lymphocyte Count | Lopinavir/Ritonavir | Change from Baseline to Week 48 (n=121,130) | 204.0 | 95% Confidence Interval 182.0 to 222.0 | cells/mm^3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00105079/results